HRES 1079 · 119th Congress · Health

Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

Introduced 2026-02-25· Sponsored by Rep. Gottheimer, Josh [D-NJ-5]· House

Bill Progress

1
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Energy and Commerce.(2026-02-25)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H. Res. 1079 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. RES. 1079 Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES February 25, 2026 Mr. Gottheimer (for himself and Mr. Bacon) submitted the following resolution; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ RESOLUTION Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health. Whereas Charcot-Marie-Tooth disease (CMT) causes damage to the peripheral nerves, which transmit information and signals from the brain and spinal cord to the rest of the body, and can also directly affect the nerves that control the muscles; Whereas it is estimated that 126,000 individuals in the…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (1)

1 Republican